The Conversation: Australian federal court upholds gene patents

September 8, 2014

Print This Post Print This Post

Biotechnology companies will be permitted to hold patents on genes in Australia after a decision by the full bench of the Federal Court, writes Reema Rattan in The Conversation.

The court found companies can hold patents in Australia over isolated biological material, in this instance, fragments of DNA that are defined as BRCA1 gene mutations, said adjunct professor of law at Murdoch University Luigi Palombi.

The BRCA1 and BRCA2 gene mutations predispose women with a familial history to developing breast and ovarian cancer.

Professor Palombi argues the decision could have a broad impact in Australia.

To read the full article, click here.

Media contact: Jo Manning
Tel: (08) 9360 2474  |  Mobile: 0408 201 309  |  Email: j.manning@murdoch.edu.au
Categories: General
Tags: , ,

Leave a comment

You can use these tags : <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

We read every comment and will make every effort to approve each new comment within one working day. To ensure speedy posting, please keep your comments relevant to the topic of discussion, free of inappropriate language and in-line with the editorial integrity of this newsroom. If not, your comments may not be published.

Thanks for commenting!